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https://doi.org/10.1016/j.molcel.2020.05.025SUMMARYIt is widely assumed that decreasing transcription factor DNA-binding affinity reduces transcription initiation
by diminishing occupancy of sequence-specific regulatory elements. However, in vivo transcription factors
find their binding sites while confronted with a large excess of low-affinity degenerate motifs. Here, using the
melanoma lineage survival oncogene MITF as a model, we show that low-affinity binding sites act as a
competitive reservoir in vivo from which transcription factors are released by mitogen-activated protein ki-
nase (MAPK)-stimulated acetylation to promote increased occupancy of their regulatory elements. Conse-
quently, a low-DNA-binding-affinity acetylation-mimetic MITF mutation supports melanocyte development
and drives tumorigenesis, whereas a high-affinity non-acetylatablemutant does not. The results reveal a par-
adoxical acetylation-mediated molecular clutch that tunes transcription factor availability via genome-wide
redistribution and couples BRAF to tumorigenesis. Our results further suggest that p300/CREB-binding pro-
tein-mediated transcription factor acetylation may represent a common mechanism to control transcription
factor availability.INTRODUCTION
Transcription factors interpret and integrate the output from
signal transduction pathways to impose gene expression pro-
grams that underpin development and homeostasis, while their
deregulation drives cancer progression. The recognition of
specific DNA sequence elements in promoter or enhancer re-Molecular Cell 79, 1–16
This is an open access article undgions determines which genes are regulated by individual
transcription factors. The repertoire of sites available is restricted
by nucleosomes, but for the binding motifs that are accessible,
occupancy is determined by a combination of abundance and
affinity of the transcription factor for DNA, combined with the
affinity of the binding site for the transcription factor. Increasing
the dwell time of a transcription factor on a DNA-recognition, August 6, 2020 ª 2020 The Authors. Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Genome-wide Binding by MITF
(A) Genome browser screenshots derived from ChIP-seq using anti-HA antibody of 501mel cells stably expressing ectopic HA-tagged MITF.
(B) Consensus motif for the most significant 900 genome-wide MITF-binding sites predicted from 60-bp regions around peak summits generated by MEME.
(C) The proportion of peaks with or without a 50-TCA(T/C)GTGN-30 motif at different peak heights.
(D) Relationship between motif frequency and peak height as in (C).
(legend continued on next page)
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Consequently, it is widely assumed that decreasing the affinity of
a transcription factor for DNA will impair its capacity for gene
regulation. However, for each sequence-specific regulatory
element, the genome contains many more degenerate variants
that could potentially act as a competitive reservoir to titrate tran-
scription factor availability. In principle, regulating a transcription
factor’s DNA-binding affinity could facilitate exchange between
such a reservoir and its regulatory elements. Whether mamma-
lian cells use regulated genome-mediated titration to tune the
effective concentration of a transcription factor is not known.
The wide-ranging biological functions and defined target
elements of the basic-helix-loop-helix-leucine zipper (bHLH-LZ)
microphthalmia-associated transcription factor MITF (Hodgkin-
son et al., 1993) in melanoma and melanocyte biology make
it an excellent model for understanding transcription factor dy-
namics in mammalian cells. MITF (Goding and Arnheiter, 2019),
a lineage survival oncogene (Garraway et al., 2005), coordinates
differentiation, regulates proliferation, suppresses migration/inva-
siveness and tumor-initiation capacity, and controls lysosome
biogenesis, autophagy, and drug sensitivity (Carreira et al.,
2005, 2006; Cheli et al., 2011; Dugo et al., 2015; Hoek et al.,
2008; Konieczkowski et al., 2014; M€uller et al., 2014; Ploper
et al., 2015; Zhang et al., 2015; Mo¨ller et al., 2019). It also sup-
presses senescence (Giuliano et al., 2010). Like other bHLH or
bHLH-LZ family members, MITF recognizes 6-bp E-box motifs,
with flanking sequences permittingMITF and other E-box-binding
factors to discriminate between related target sites (Aksan and
Goding, 1998; Blackwell and Weintraub, 1990; Fisher et al.,
1993; Fisher and Goding, 1992; Hejna et al., 2019; Solomon
et al., 1993). Despite the key role of MITF in melanoma progres-
sion, surprisingly little is known about how its target gene selec-
tivity is modulated. Although mitogen-activated protein kinase
(MAPK) signaling regulates MITF nuclear export (Ngeow et al.,
2018) and enhances interaction with the transcription cofactor
CREB-binding protein (CBP)/p300 (Price et al., 1998), how the de-
regulated BRAForNRAS signaling that drivesmelanomaprogres-
sion otherwise affects MITF’s capacity to regulate gene expres-
sion is poorly understood.
Here, we reveal that paradoxically, BRAF-activated p300-
mediated acetylation of a transcription factor can increase its
function in vivo by decreasing its DNA-binding affinity.
RESULTS
Genome-wide Distribution of MITF
Differentiation-associated MITF target genes possess a
conserved M-box (Lowings et al., 1992) comprising a CATGTG
E-box motif flanked by 50T and/or 30A residues (Aksan and God-
ing, 1998). By contrast, several MITF targets apparently have E-
box elements lacking the 50T and 30A flanking residues including
MET, KIT, BCL2, HPGDS, and TPSB2 (Cheli et al., 2010). How
MITF might discriminate between these binding sites is not(E) Sequences associated with a selection of differentiation or non-differentiation
(F) Box and whisker plots of peak height related to motif. Center of notches indica
of well-characterized differentiation-associated genes in addition to many other
See also Figure S1 and Table S1.known. To address this issue, we performed chromatin immuno-
precipitation coupled to high-throughput DNA sequencing
(ChIP-seq) using an established (Laurette et al., 2015) 501mel
melanoma cell line expressing hemagglutinin (HA)-epitope-
tagged MITF (Figures S1A and S1B, upper panel). The results
confirmed binding to known MITF target genes, including
differentiation genes containing conserved CATGTG motifs
such as TYR (Figure 1A; Figure S1B, lower panel); TRPM1 and
DCT (Figure 1A); ATF4, a mediator of the integrated stress
response; and LAMP1 and HEXA, lysosomal biogenesis genes
that contain CACGTG-binding motifs. In each case, the core 6-
bp binding motif was flanked by 50T and/or 30A residues that
differentiate betweenMITF andMYC targets (Aksan andGoding,
1998; Fisher et al., 1993; Fisher and Goding, 1992; Hejna et al.,
2019; Solomon et al., 1993). No binding was observed at the
mast-cell-specific HPGDS and TPSB2 loci. At the MET, KIT, or
BCL2 genes, MITF recognized intronic motifs (Figure S1C),
rather than their promoters as reported previously (McGill
et al., 2002, 2006; Tsujimura et al., 1996). Thus, MITF-binding
sites contain motifs with a 50T and/or 30A and flanking sequences
do not distinguish between targets associated with MITF’s
different biological functions such as proliferation or differentia-
tion. Consistent with this, the consensus motif for MITF recogni-
tion was TCACGTGA (Figure 1B), reflecting that CACGTGmotifs
are enriched among the highest affinity binding sites.
MITF ChIP peak heights varied between genes (Figure 1A) and
the proportion of peaks with binding motifs increased with peak
height (Figure 1C). Of the peaks called, high peak heights were
associated with CACGTG elements with the flanking T-residue
characteristic of MITF binding, whereas CATGTG motifs related
to the differentiation-associated M-box sequence exhibited
lower peak heights, consistent with a lower affinity for MITF (Fig-
ure 1D). As reported previously (Goding, 2000), differentiation-
associated genes, with the exception ofMLANA, which contains
a CACGTG element, possess core CATGTG motifs and exhibit
peak heights between 60 and 100 (Figure 1E). By contrast,
many other MITF targets, frequently associated with proliferation
or lysosome biogenesis genes (Ploper et al., 2015; Zhang et al.,
2015), had substantially higher peak heights (Figure 1E).
Analyzing peak height distribution relative to motif beneath the
peak (Figures 1F and S1D) revealed that the highest ChIP peaks
(median height, 152) possessed double MITF 8-bp binding sites
and the next-highest possessed single TCACGTGA motifs (me-
dian height, 51). The more than additive peak heights associated
with double binding sites suggest that MITF dimers may bind
cooperatively. Thus, peak heights tend to diminish with varia-
tions from the consensus 8-bp TCACGTGA element, indicating
that for most sites, peak height reflects the binding motif. Note
that the median peak height corresponded well to the MITF-
bound sequence (Figure 1F), but each motif was associated
with a considerable range, most likely reflecting the position of
each recognition element relative to nucleosomes or binding
sites for cooperating transcription factors.-associated MITF target genes.
tes the median. Green box indicates range of peak heights within which lie a set
non-differentiation genes.
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Figure 2. MITF Can Be Acetylated
(A) Indicated expression vectors were transfected into Phoenix cells and input and anti-FLAG immunoprecipitates western blotted.
(B) Western blot of 501mel cells treated with 200 nM TPA for indicated times.
(C) Western blot of extracts from cells transfected with BRAF and/or p300 expression vectors.
(D) Western blot of Phoenix cells transfected with indicated vectors and HA-MITF, ±20 mM U0126 immunoprecipitated using anti-HA antibody.
(E) Schematic showing the melanocyte-specific MITF-M(+) isoform. The five acetylated lysine residues identified in MITF-M peptides by mass spectrometry are
indicated below. ERK, p38, and RSK phosphorylation sites are indicated above with the CBP/p300-binding site.
(F) MITF DNA-binding domain-DNA co-crystal structure showing the MITF K243-DNA phosphate-backbone contact.
(G) Conservation of K243 between bHLH and bHLH-LZ family members.
(legend continued on next page)
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TCACGTGA motifs (Figure 1F), the range of peak heights for dif-
ferentiation genes (60–100) (Figure 1E; Table S1) was similar to
the top range of TCACGTGA elements. It was also among the
very highest for TCATGTGA motifs in general (Figure 1F); of
23,500 peaks with single TCATGTGA motifs bound by MITF,
almost 19,000 exhibited peaks lower than the bottom end of
the range, and only 0.2% had peak heights above. Since
peak height may reflect affinity for a particular element, DNA-
binding affinity does not distinguish between well-characterized
differentiation-associated MITF targets and non-differentiation
MITF targets.
To eliminate the possibility that the expression of HA-tagged
MITF and the endogenous protein could produce different re-
sults, we also re-analyzed a ChIP-seq dataset obtained from
melanocytes using an anti-MITF antibody (Webster et al.,
2014). The results were similar with differences likely accounted
for by the reduced number of peaks in the Webster et al. dataset
compared to ours, reflecting the high ChIP efficiency when using
the anti-HA antibody. Thus, the consensus MITF recognition
motif is similar (Figure S1E), mean peak height tends to reduce
when the binding site varies from the consensus (Figure S1F)
and binding to genes such as ATF4 and LAMP1 is located in a
similar position (Figure S1G).
MITF Is Acetylated on a Highly Conserved Phosphate-
Backbone-Interacting Lysine
DNA-binding affinity is dictated by a combination of base-spe-
cific contacts that provide sequence specificity and contacts
with the phosphate backbone. We hypothesized that as MIT-
F-occupied sites exhibit a wide range of peak heights, the
relative distribution of MITF binding between low- and high-affin-
ity targets might be regulated through alteration of MITF’s
DNA-binding affinity.
The CBP and p300 lysine acetyl transferases are cofactors for
a wide range of transcription factors and are proposed to facili-
tate transcription activation via histone acetylation. However,
CBP and p300 also acetylate transcription factors (Boyes
et al., 1998; Bricambert et al., 2010; Cesen˜a et al., 2007; Daitoku
et al., 2004; Giandomenico et al., 2003; Gu and Roeder, 1997;
Perrot and Rechler, 2005; Ponugoti et al., 2010). As MITF inter-
acts with CBP and p300 (Price et al., 1998; Sato et al., 1997),
we askedwhether MITF is acetylated. Examination of MITF acet-
ylation was initially frustrated by an inability to extract the protein
from the nuclei of IGR37 or 501mel melanoma cells; using
increasingly stringent conditions, including lysonase to digest
nucleic acid or 2 MNaCl, the great majority of MITF was retained
in the nuclear pellet (Figure S2A). By contrast the bHLH-LZ factor
USF or the POU domain transcription factor BRN2 were readily
extracted. To circumvent this problem, we co-expressed
epitope-tagged MITF with CBP or p300 to generate sufficient
soluble MITF for immunoprecipitation. Western blotting using
anti-acetyl lysine antibody after immunoprecipitation revealed(H) Peptide array containing indicated residues as 14-amino-acid peptides immo
(I) Western blot using anti-acetyl K243 or anti-MITF antibodies of immunoprecip
(J) Western blot using anti-acetyl K243 or anti-MITF antibodies of HIS-tagged M
See also Figure S2.both CBP and p300 substantially increased MITF acetylation
(Figure 2A).
Since the MAPK pathway is frequently activated in melanoma
via mutation of BRAF or NRAS and p300 acetyl transferase
activity is enhanced by MAPK-mediated phosphorylation in
keratinocytes (Chen et al., 2007), we asked whether MAPK
signaling activates acetylation in melanoma. Stimulation of
melanoma cells with 12-O-tetradecanoylphorbol-13-acetate
(TPA) transiently activated MAPK signaling detected using anti-
phospho-ERK antibody, followed by a prolonged increase in his-
tone H3 acetylation (Figure 2B). Cells were also transfected with
expression vectors for Myc-epitope-tagged BRAFV600E, HA-
tagged p300, or both, and whole-cell extracts were probed
with anti-acetyl lysine antibody. Whereas p300 increased
acetylation compared to untransfected cells, no increase was
observed in cells transfected with BRAFV600E alone, though
phospho-ERK levels were increased (Figure 2C). By contrast,
co-transfection of BRAFV600E together with p300 dramatically
increased global acetylation. In agreement, MITF acetylation
driven by either p300 or CBP was blocked using the MEK
inhibitor U0126 (Figure 2D). These data suggest that MITF
acetylation is increased by activation of MAPK signaling, a
hallmark of melanoma.
Mass spectrometry of immunoprecipitated Myc-tagged
MITF revealed acetylation on five lysines (K21, K33, K43,
K243, and K248) (Figures 2E, S2B, and S2C). Significantly,
the MITF-DNA co-crystal structure (Pogenberg et al., 2012) re-
vealed that K243, located at the 30 end of the bHLH-LZ loop,
makes a phosphate backbone contact but does not bind any
base (Figure 2F). MITF K243 is highly conserved between
species and most bHLH and bHLH-LZ transcription factors
(Figure 2G) and makes a similar phosphate-backbone contact
in all available crystal structures (Figure S2D). By contrast,
K248 does not contact the DNA and is poorly conserved,
except in the MITF family. Molecular modeling (Figure S2E)
suggested that acetylation of K243 in MITF would disrupt the
phosphate backbone contact. As such, acetylation of K243
should reduce the affinity of MITF for DNA without directly
altering its target specificity.
To confirm acetylation of MITF K243, we generated an anti-
acetyl-MITF-K243 antibody. Using an array of MITF peptides
containing acetyl and non-acetyl residues corresponding to
K243 or other acetylated lysines (K21, K33, and K43), control
MITF residues (K205 and K206), or histone H3 peptides contain-
ing K27 and K9 (Figure 2H), we determined that the antibody was
largely specific for the acetyl-K243 residue. The anti-acetyl-
MITF-K243 antibody efficiently recognized immunoprecipitated
MITF-GFP co-expressed with p300 or CBP (Figure 2I) or stably
expressed polyhistidine-tagged MITF (purified using nickel
beads after urea extraction) without ectopic p300 or CBP (Fig-
ure 2J). Note that despite extensivemass spectrometry analyses
for this and other studies, we have not identified any other post-
translational modification on this residue.bilized on a cellulose membrane probed with rabbit anti-acetyl-K243 antibody.
itated GFP-MITF expressed alone or with co-transfected CBP or p300.
ITF purified with nickel beads. All samples were from the same blot.
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Figure 3. K243 Status Determines MITF DNA-Binding Affinity
(A) Comparison of circular dichroism (CD) spectra of bacterially expressed and purifiedMITFWT andmutant DNA-binding domains. Themean residue ellipticity is
plotted in dg 3 cm2 3 dmol1 against the wavelength (in nm). CD spectra show the mutations cause no major structural changes.
(B) DNA-binding affinity of bacterially expressed and purified MITF WT and mutant DNA-binding domains determined using fluorescence anisotropy. Repre-
sentative titration curves of each fluorescein-labeled oligonucleotide with MITF WT and mutants. The anisotropy values are the average of triplicate measure-
ments from which the baseline corresponding to the anisotropy of the free fluorescent probe was subtracted.
(C) The dissociation constants of MITF WT and mutants on oligonucleotides containing four different recognition sequences determined by fluorescence
anisotropy.
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bacterially expressed and purified the wild-type (WT) MITF
DNA-binding domain as well as K243R and K243Q mutants.
Molecular modeling (Figure S2E) predicted that a K243R
mutant would maintain the phosphate backbone contact,
whereas the glutamine substitution, widely used as an imper-
fect acetylation mimetic (Mishra et al., 2016; Wang and Hayes,
2008), would break the contact and consequently impair DNA
binding. Characterization of the proteins by circular dichroism
indicated that both mutants had a similar structure to the WT
(Figure 3A).
We next used fluorescence anisotropy to determine the
in vitro DNA-binding affinity of all three proteins on four
different binding sites: a full consensus 8-bp TCACGTGA
motif termed a coordinated lysosomal expression and regula-
tion (CLEAR) box, a CACGTG E-box lacking the key flanking
50T and 30A residues, a TCATGTGT M-box motif associated
with the tyrosinase promoter, and a mutated (half-site) CLEAR
box as a negative control. The DNA-binding data (Figure 3B)
and summary of affinities (Figure 3C) revealed the WT protein
bound the CLEAR box with the highest affinity and that MITF
exhibited around an 11-fold reduced affinity for the differenti-
ation-associated M-box element. Compared to WT MITF, the
K243R mutant bound 4-fold less well on all sites. The DNA-
binding affinity of the K243Q mutant was further reduced6 Molecular Cell 79, 1–16, August 6, 2020compared to the K243R mutant. K243Q bound the CLEAR
box almost 7-fold less well than the WT protein and 2-fold
less than the K243R mutant. Binding by the K243Q mutant
was 21-fold reduced compared to the WT on an E-box and
35-fold reduced compared to the WT on an M-box, and it ex-
hibited 5-fold and 8.7-fold reduced binding to these elements,
respectively, compared to the K243R mutant. The binding af-
finity of all three proteins was further reduced when using the
mutated CLEAR box element, but it was especially low for the
K243Q mutant. In summary, the in vitro DNA-binding affinities
of the WT and K243R and K243Q mutants confirmed that
K243 contributes to the DNA-binding affinity of MITF and
that the K243Q acetylation mimetic reduced DNA-binding af-
finity substantially more than the K243R mutation.
K243 Plays a Critical Role in Development and
Tumorigenesis
To investigate the impact of K243 status in vivo, we used MITF
WT or mutants to complement the absence of MITF in an
mitfa-null nacre zebrafish. As expected, WT mitfa restored
melanocyte numbers (Figures 4A and S3). However, surpris-
ingly, the high-affinity DNA-binding K243R mutant (K238
in fish) was inactive, whereas the low-affinity K243Q
mutant effectively complemented the nacre mutation. Thus,
paradoxically, the K243Q mutant that binds DNA in vitro
Figure 4. K243 Controls MITF Function
In Vivo
(A) Complementation of neural crest MITFa-null
nacre zebrafish usingMITFWT andK238 (equivalent
to K243 in human MITF) mutants (left) and quantifi-
cation of numbers of melanocytes (right). The dots in
the plots represent numbers of melanocytes in each
rescued embryo with at least one melanocyte. See
also Figure S3.
(B) Western blot of 501mel cells stably expressing
HA-MITF WT and mutants (from the same gel).
(C) Tumor formation after subcutaneous inoculation
of indicated cell lines into athymic nude mice.
(D) Example tumors.
(E) Tumor size over time using indicated cell lines.
Error bars indicate S.E.M.
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In addition to its role in melanocyte development, MITF also
plays a key pro-proliferative role in melanoma (Goding and
Arnheiter, 2019; Carreira et al., 2006; Garraway et al., 2005;
Giuliano et al., 2010; Hoek and Goding, 2010; Widlund
et al., 2002). We therefore asked whether the status of K243
would affect melanoma growth by stably expressing
HA-tagged MITF WT and the K243R and K243Q mutants in
the poorly tumorigenic 501mel human melanoma cell line.
Western blotting revealed that the ectopic MITF, which runs
as two bands corresponding to hyper- and hypo-phosphory-
lated forms, was expressed 2- to 3-fold more than the
endogenous protein (Figure 4B). In culture, we were unable
to detect major differences in gene expression or proliferation
rate between cells expressing ectopic WT or mutant MITF (not
shown), likely owing to the expression of the endogenous
MITF. However, in vivo endogenous MITF can be transcrip-
tionally downregulated in xenograft tumors (Thurber et al.,
2011) as well as in human melanoma (Goodall et al., 2008).
We therefore asked whether the cell lines expressing WT
MITF or the K243R or K243Q MITF mutants exhibited differen-
tial tumor-forming potential following subcutaneous injection
into athymic nude mice. The results showed that parental
501mel cells failed to form tumors, whereas 501mel cells ex-
pressing HA-tagged WT MITF formed tumors in 3 out of 10
cases (Figures 4C–4E), consistent with MITF promoting
tumorigenesis. Cells expressing the MITF K243R mutant failed
to form tumors, but by contrast, K243Q-expressing cells
formed large rapidly growing tumors in 10 out of 10 cases.
The A375 melanoma cell line was used as a positive control.
Thus, MITF K243 status is a major determinant of melanoma
tumorigenicity as well as melanocyte development. Note
that whereas in the zebrafish assay or cells in culture, thesimilar behavior of the WT and K243Q
mutant suggests functional MITF may
be highly acetylated, in the tumor-forma-
tion assay, WT MITF has an intermediate
phenotype between the K243R and the
K243Q mutants. This may indicate that
WT MITF in the tumor-formation assay
may be only partially acetylated, perhapsbecause the microenvironment after subcutaneous injection is
very different from that in development or 501mel cells in
culture.
K243 Status Determines the Genome-wide Distribution
of MITF
The contrasting biological output from the K243R and K243Q
mutants was unlikely to arise because of differential co-factor
interactions, since mass spectrometry analysis (not shown)
failed to identify substantial differences in their associated
proteins. We therefore hypothesized that the K243R and
K243Q mutants would exhibit differential DNA binding in vivo.
To test this, we performed an initial ChIP-seq experiment on
human 501mel melanoma cells stably expressing similar levels
of HA-epitope-tagged MITF WT and K243R or K243Q mutants
(Figure S4A), an approach used previously to show altered
targeting of the melanoma-associated MITF E318K mutant
(Bertolotto et al., 2011). Some genes such as HEXA, which con-
tains two MITF target sites, exhibited little difference in occu-
pancy between WT and K243R or K243Q mutants (Figure S4A,
left). By contrast, theMITF K243Rmutant, but not K243Q, bound
less well than WT to differentiation-associated target genes
such as MLANA (Figure S4A, right). These data provided an
indication that on some genes, the K243R mutant exhibited
impaired binding compared to the lower affinity K243Q mutant.
To eliminate the possibility that the 2- to 3-fold elevated
MITF WT or mutant levels expression in the cell lines used for
the ChIP-seq could affect the outcome, we engineered 501mel
cells to express doxycycline-inducible HA-tagged MITF WT
and K243 mutants. Western blotting (Figure S4B) using different
concentrations of doxycycline revealed that the levels of ectopic
WT and mutant MITF could be titrated. At 0 ng doxycycline,
the ectopic MITF proteins were barely detectable, and at
20 ng, the levels were similar to the endogenous protein.Molecular Cell 79, 1–16, August 6, 2020 7
(legend on next page)
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largely nuclear (Figure S4C).
Using the inducible cell lines, we repeated the ChIP-seq using
theWT andmutant HA-taggedMITF proteins at both 0 and 20 ng
doxycycline, with replicates exhibiting a high level of reproduc-
ibility (Figure S4D). Characterization of the ChIP efficiency and
ratio of peaks called/input indicated that while the K243Qmutant
behaved similarly to the WT protein, the K243R mutant bound
less well (Figure S4E). Examining peak distribution also showed
similar binding by the WT and K243Q mutant. The increase in
expression from 0 to 20 ng doxycycline was reflected in
increased binding genome-wide (Figure 5A). Again, binding by
the K243R mutant at 0 ng doxycycline was severely diminished
compared to the WT or K243Q mutants, but it was increased
at 20 ng. The total number of peaks called using WT MITF at
0 ng was close to 50,000, which increased to 100,000 at
20 ng, confirming that increasingMITF expression leads to occu-
pancy of more sites (Figure 5B). Similar results were obtained
with the K243Q mutant. By contrast, the K243R mutant bound
much less well, and even at 20 ng doxycycline, the number of
peaks was 30% of the WT or K243Q mutant. The average
read density centered on the peaks called revealed similar re-
sults for WT MITF and K243Q mutant, but the peak scores for
the K243R mutant were reduced 4-fold and 3-fold at 0 and
20 ng, respectively (Figure 5C).
Using the H3K27Ac epigenetic modification as a marker of
enhancers (Verfaillie et al., 2015) and 1 kb distance from the
transcription start site as promoter location, we found no differ-
ences in distribution of MITF WT or K243Q mutant. The great
majority of binding sites at both 0 or 20 ng doxycycline were
located either in enhancers or in non-promoter locations (Fig-
ure S4F). A slightly different profile was observed using the
K243Rmutant, where at 0 ng doxycycline, increased relative oc-
cupancy of promoter and enhancer sites was observed, but at
20 ng, the profile was similar to that of the WT and K243Q
mutant. The different distribution of K243R at 0 ng is most likely
related to the greatly reduced number of peaks called
(Figure 5B).
Examining individual MITF-regulated genes again revealed
that WT and MITF K243Q mutant bound similarly, but the
K243R mutant exhibited reduced binding, especially at those
genes with the lower affinity TCATGTG M-box elements such
as PMEL or DCT (Figures 5D and S4G). Comparing binding to
different motifs (Figure 5E) revealed that at 0 ng doxycycline,
the mean peak score was lower for K243R than WT, while that
of the K243Q mutant was higher, especially for genes bearing
two CLEAR-box motifs. At 20 ng doxycycline, where HA-taggedFigure 5. K243 Status Determines MITF Genome-wide Distribution
(A) Heatmap of MITF WT and K243 mutant average tag density derived from two b
0 or 20 ng doxycycline centered on WT occupied regions (20 ng doxycycline).
(B) Numbers of ChIP peaks called using HA-tagged MITF WT or mutants induce
(C) Read coverage of two replicates for each of the WT and K243 mutant ChIP-se
coordinates of the WT at 5-bp binning intervals. Numbers on the x axis indicate
(D) Genome browser screenshots of indicated loci showing HA-taggedWT and m
at 0 or 20 ng doxycycline as indicated.
(E) Box and whisker plots showing peak score for two replicate (R1 and R2) ChI
motifs. Expression of HA-MITF WT and mutants induced at 0 or 20 ng doxycycli
See also Figure S4.MITF was expressed at levels similar to endogenous MITF in
the parental cell line (Figure S4B), binding by K243Q and WT
MITFwas similar at all motifs, but the K243Rmutant again bound
less well to all classes of binding site.
Single-Molecule Tracking (SMT) of MITF Binding in Cells
Since the read density of the ChIP-seq experiments using
MITF WT and the two mutants was normalized to the total
mapped reads, the reduced peak heights associated with the
K243R mutant means that there is an increase in reads distrib-
uted elsewhere within the genome that are not within peaks
that pass the statistical threshold in the peak-calling algorithm.
This result was unlikely to be an artifact, as it was highly repro-
ducible across multiple ChIP-seq experiments using different
concentrations of doxycycline (Figures 5 and S4D–S4G) as
well as in the non-inducible stably expressing cell lines
(Figure S4A).
In an orthogonal approach to understanding the paradoxical
discordance between in vitro binding by the K243 mutants and
their binding in vivo, we used SMT to examine the kinetics of
WT and mutant MITF binding to chromatin in live cells. In this
approach (Tokunaga et al., 2008), HALO tagged-transcription
factors are labeled with sub-saturating concentrations of a
bright, photostable fluorescent ligand, JF594 (Grimm et al.,
2015). This allows an estimation of the diffusion properties
of labeled molecules, the fraction of transcription factor
immobilized in the nucleus, and the duration of the binding
events (Gebhardt et al., 2013; Mazza et al., 2012, 2013). To
this end, we generated 501mel cells stably expressing doxycy-
cline-inducible HALO-tagged WT and K243 mutant MITF (Fig-
ure 6A). We also expressed a non-DNA-binding mutant of
MITF (Dbasic) lacking the basic region required for sequence-
specific DNA binding (Fock et al., 2019). Because the basic re-
gion contributes to MITF nuclear localization (Fock et al.,
2019), we fused HALO-tagged WT and mutant MITF to the
SV40 T-antigen nuclear localization signal (Kalderon et al.,
1984). After induction of MITF expression using 20 ng doxycy-
cline, nuclei expressing HALO-MITF were imaged (Figure 6B;
Videos S1, S2, S3, and S4).
We modeled the distribution of single-molecule displace-
ments for WT MITF tracks collected at 100 frames per second
(fps) with a three-component diffusion model (Hansen et al.,
2018; Loffreda et al., 2017; Speil et al., 2011) (Figure 6C) and
determined that 43% of molecules were immobilized, 34%
were found in a slow diffusion state with Dslow = 0:34 mm
2=s,
and the remaining molecules were in a fast diffusion state with
Dfast = 1:7 mm
2=s (Figure 6D). Transcription factors explore theiological replicate ChIP-seq experiments of HA-tagged MITF expressed using
d using 0 or 20 ng doxycycline. See also Table S2.
q experiments expressed using 0 or 20 ng doxycycline centered around peak
distance from center of the peak (in bp).
utant MITF ChIP-seq profiles from iMITF cell lines expressing HA-tagged MITF
P-seq experiments for the WT and two K243 mutants related to the indicated
ne. Colored line indicates median, and black line indicates mean.
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Figure 6. Live-Cell Single-Molecule
Tracking (SMT) of HALO-Tagged MITF
(A) HALO-tagged MITF expression vectors. NLS
indicates the nuclear localization sequence. Dba-
sic lacks residues required for DNA binding.
(B) Exemplary frames of SMT movies using WT
and mutant HALO-tagged MITF, collected at 100
fps (see also Videos S1, S2, S3, and S4). Scale bar,
5 mm. Labeling with 100 pM Halotag JF 594 allows
particle densities in the range of a few molecules
per frame.
(C) SMT movies were tracked to generate a dis-
tribution of single-molecule displacements be-
tween consecutive frames that was fit with a three-
component model (one immobile component and
two diffusing components) to provide quantitative
estimates for WT MITF and mutants shown in (D)
and (E). Cmp, component.
(D) Quantitative estimates derived from SMT using
WT andmutant HALO-taggedMITF for the fraction
of molecules in each state. Error bars indicate SD.
(E) Quantitative estimates of the diffusion co-
efficients of free molecules. For MITF WT, Dbasic,
K243Q, and K243R, respectively, Ncells = 20; 6; 15;
15; Ndisplacements = 17802; 2684; 16422; 12999.
Error bars indicate SD.
(F) Summary derived from the SMT analysis of
proportion of MITF calculated to bind high- versus
low-affinity sites.
(G) Electrophoretic mobility shift assay (EMSA)
using bacterially expressed and purified WT and
mutant MITF DNA-binding domains, a 30-bp
TCACGTGA-motif-containing probe, and compe-
tition with 4-fold dilutions of SSD (10 mg to 2.3 fg).
Bound DNA is shown. Probe was in excess in all
reactions.
(H) EMSA as in (G) with competition by indicated
competitor oligonucleotides at 3, 10, and 30 ng.
Bound DNA is shown.
See also Figures S5 and S6 and Videos S1, S2, S3,
and S4.
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which is 3- to 10-fold slower than expected for inert tracers
of comparable sizes. Such slowdown in diffusion has been inter-
preted as an effect of molecular crowding in the nucleus (Izeddin
et al., 2014; Mazza et al., 2012) or transient nonspecific interac-
tions with chromatin on a timescale faster than the acquisition
frame rate (Elf et al., 2007; Michelman-Ribeiro et al., 2009), a
phenomenon known as effective diffusion (Sprague et al., 2004).
To interpret the measured immobile fractions and diffusion
coefficients, we repeated the SMT analysis using the MITF-Dba-
sic mutant (Figures 6B–6D). MITF-Dbasic displayed a 4-fold
drop in its immobile fraction, indicating that the WT-MITF-bound
fraction largely arises owing to its interactions with DNA-binding
sites. The duration of these stable MITF-binding events typically
last for several seconds (Figure S5A), as reported for themajority10 Molecular Cell 79, 1–16, August 6, 2020of transcription factors studied by SMT
(Chen et al., 2014; Gebhardt et al., 2013;
Loffreda et al., 2017; Sugo et al., 2015;
Teves et al., 2016). The slow and fastdiffusion coefficients of the diffusing populations of MITF-Dbasic
were2-fold higher than that observed for WTMITF, supporting
the hypothesis that diffusing WT molecules are slowed down by
low-affinity binding events lasting a few milliseconds at most
(Figure 6E).
We next performed SMT on cells expressing the HALO-MITF
K243Q and K243R mutants. While the K243Q mutant displayed
a minor decrease in immobile fraction (<20%) (Figures 6C and
6D), the MITF K243R mutant exhibited a more pronounced
drop in its immobile fraction (2.5-fold) and a corresponding in-
crease in the effective slow and fast diffusing fractions (Figures
6C and 6D). However, surprisingly, SMT did not reveal any sub-
stantial difference in the residence time of MITF WT and K243
mutants (Figures S5A–S5D). Thus, compared to the WT and
K243Q mutant, the K243R mutant exhibits a reduced immobile
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(Figure 6E). The SMT data therefore support the ChIP observa-
tions; K243Q behaves dynamically very similarly to WT MITF
(although with a marginally reduced immobile fraction), whereas
the K243R mutant has its binding equilibrium shifted toward
an unbound or transiently bound (effective diffusion) state. In
other words, by binding transiently but frequently to low-affinity
sites genome-wide, the K243R mutant is less able to bind
higher affinity sites associated with gene regulation.
If we assume that the measured immobile fraction by SMT
reflects specific long-lived binding and that the slowdown in
diffusion (compared to MITF-Dbasic) is due to nonspecific tran-
sient binding, we can use the estimates from the SMT data to
calculate the number of high-affinity and low-affinity binding
sites bound at any time. By this calculation, long-lived binding
events occur 1.5 times more frequently than transient binding
events for WT MITF (Figure 6F). This ratio is slightly reduced
for MITF-K243Q (1.1–1.4 times), while it is 3-fold lower for
MITF-K243R (0.4–0.5 times). These data are in very good agree-
ment with the ChIP-seq performed using WT and mutant MITF.
To confirm these data, we also performed an SMT-based
competition assay (Figure S6A). Using a cell line stably express-
ing WT HALO-MITF, we introduced expression vectors for
doxycycline-inducible GFP-tagged WT and K243R and K243Q
mutants and determined the bound and slow- and fast-diffusing
fractions. The results (Figures S6B and S6C) indicate that the
bound fraction of the stably expressed HALO-MITF WT is sub-
stantially reduced when the K243Q mutant is expressed, but
not when the K243R mutant is expressed. The WT exhibits an
intermediate effect, consistent with it being partially acetylated.
As an additional control, we also determined the bound and
slow- and fast-diffusing factors for a stably expressed MITF
mutant bearing a quadruple K > R substitution in the four addi-
tional acetylation sites identified here (K21, K33, K43, and
K248) (Figure S6D). The 4KR mutant exhibited a similar distribu-
tion of displacements (Figure S6E), bound (Figure S6F) and fast
diffusing coefficient (Figure S6G) as the WT MITF. This indicates
that these additional acetylated residues are unlikely to
contribute to MITF DNA-binding activity. This result was
confirmed using ChIP-PCR to compare occupancy of WT MITF
to that of the 4KR mutant on a set of MITF-binding sites. No sig-
nificant differences in occupancy were apparent (Figure S6H).
K243 Status Dictates Titration by Genomic DNA
To characterize the equilibrium between MITF specific and
nonspecific binding in vitro, we performed a DNA-binding elec-
trophoretic mobility shift assay using a radiolabeled probe con-
taining a high-affinity TCACGTGAMITF recognition site together
with bacterially expressed and purified MITF WT and K243 mu-
tants. Binding to the probe was challenged with increasing
amounts of salmon sperm genomic DNA (SSD) as competitor
to reflect the presence of genomic DNA present within nuclei.
The results showed that bacterially expressed WT MITF (non-
acetylated) or K243R mutant were similarly competed by the
SSD from binding the consensus TCACGTGA probe (Figure 6G).
By contrast, 256-fold more SSD was required to similarly
compete the K243Q mutant. All three proteins were competed
well by a cold TCACGTGA consensus competitor, andmutationsinmore than one base of thismotif prevented binding (Figure 6H).
However, the K243R and WT, but not the K243Q, proteins were
also competed by a low-affinity TCACGTTA motif. These result
can be explained by higher affinity binding by the K243R mutant
conferred by the additional phosphate-backbone contact
enabling it to bind the genome-wide excess of weaker binding
sites that diverge from the consensus. Thus the in vitro DNA-
binding assays are in agreement with both the SMT and
ChIP-seq analyses, and collectively, the data confirm the
paradoxical result that a transcription factor with reduced
DNA-binding affinity in vitro (MITF K243Q) can function better
in vivo than a higher affinity binding protein (K243R).
Finally, for at least two transcription factors, p48 (PTF1A;
involved in pancreatic acinar cell differentiation; Rodolosse
et al., 2009) and the neuronal differentiation 1 (NEUROD;BETA-
2) bHLH factor (implicated in pancreatic islet cell development
and function; Qiu et al., 2004), the equivalent lysine is acetylated
and implicated in driving gene expression. We therefore estab-
lished a stable cell line expressing similar levels of HALO-tagged
NEURODWT or K138R or K138Qmutants (K243 equivalent) and
performed SMT analysis. The results revealed that WT NEUROD
exhibited a distribution of displacements that lay between that of
the K138R and K138Q mutants (Figure S6I). As with the MITF
K243R mutant, the bound fraction of the K138R mutant was
reduced compared to the WT and K138Q mutant, with the latter
also exhibiting a reduced fast-diffusing fraction (Figure S6J) and
reduced fast diffusion coefficient (Figure S6K). Collectively,
these data suggest that the modification status of K138 in
NEUROD plays a similar role in dictating the effective available
fraction of the transcription factor as K243 in MITF.
DISCUSSION
Models of transcription regulation suggest that transcription
factors engage in extensive nonfunctional interactions within
chromatin-accessible regions (Fisher et al., 2012) and that bind-
ing to regulatory elements is intrinsically stochastic and highly
dynamic (Liu and Tjian, 2018; McNally et al., 2000). Moreover,
the probability of transcription initiation occurring is largely
determined by the affinity of the binding site for the transcription
factor (Segal and Widom, 2009). It is therefore widely assumed
that decreasing transcription factor DNA-binding affinity reduces
transcription initiation by diminishing occupancy of the
sequence-specific regulatory elements. However, our results,
obtained using MITF as a model, highlight an unexpected
paradox. The acetylation mimetic K243Q mutant exhibits
reduced DNA-binding affinity in vitro but supports melanocyte
development and tumor formation better in vivo than the non-
acetylatable higher affinity K243R mutant. The WT MITF protein
has a similar affinity for DNA as the K243R mutant in vitro, but,
consistent with WT MITF being acetylated in cells, it instead
supports melanocyte development like the lower affinity
K243Q mutant. The biological activity of the WT and mutants is
reflected in their relative ChIP efficiency, withWT and low-affinity
K243Qmutant binding better in cells than the high-affinity K243R
mutant. Moreover, as expected, increasing levels of MITF WT
and mutants led to increased occupancy of binding sites
genome-wide, reflected in both increased peak height andMolecular Cell 79, 1–16, August 6, 2020 11
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levels, the difference between the K243R mutant and the
WT/K243Q mutant was maintained. Explaining the paradox
that reduced DNA binding affinity in vitro translates to better
DNA binding and function in vivo provides a novel and unantici-
pated insight into transcription factor dynamics.
Counterintuitively, we propose that the simplest and most
likely explanation for the differential recognition of binding sites
in vivo by the WT/K243Q and K243R proteins is their differential
DNA-binding affinity; a genome-wide excess of very low-affinity
binding sites may be bound by a high-affinity transcription factor
such as the K243Rmutant but may not be recognized effectively
by either the K243Q mutant or an acetylated WT protein. In this
model, an excess of low-affinity sites will reduce the effective
concentration of MITF that is free to recognize the productive
binding sites that support melanocyte development and tumor
formation. This explanation was supported by our observation
that in vitro, in the absence of any co-factors, SSD titrated the
high-affinity unacetylated WT protein and the K243R mutant
better than the low-affinity K243Q mutant, leaving the K243Q
mutant better able to bind a consensus binding site. Such a
model to control transcription factor availability was originally
hypothesized for the bacterial Lac repressor (von Hippel et al.,
1974), and more recently, it was shown that in E. coli, competing
LacR-binding sites on plasmids whose copy numbers vary dur-
ing the cell cycle can have a substantial impact on the dosage
response to that transcription factor (Brewster et al., 2014).
While a large excess of degenerate, low-affinity motifs pre-
sents a thermodynamic challenge to a given transcription factor
locating and remaining at its target regulatory elements, it also
offers an opportunity for regulation. However, for a regulated
genomic titration model to be valid, the number of molecules
of a transcription factor able to bind DNA should not be in large
excess over the number of potential binding sites. In mammalian
cells, transcription factor copy numbers vary widely (Biggin,
2011), but the fact that increasing transcription factor expression
levels cause changes in gene expression and that limiting
numbers of transcription factors can be redirected to alternative
sites by binding partners (Hosokawa et al., 2018) implies that
they are not effectively in excess over their accessible DNA-
binding sites. By contrast, early observations made using
fluorescence recovery after photobleaching (FRAP) suggested
that the great majority of transcription factor molecules in a cell
are fast diffusing and are therefore potentially in excess over
their binding sites (McNally et al., 2000; Sprague et al., 2004;
Stenoien et al., 2001). However, as a population technique,
FRAPmay fail to dissect the behavior of multiple coexisting pop-
ulations (e.g., stably bound, transiently bound to nonspecific
sites, or freely diffusing). Instead, we used SMT to address the
dynamic behavior of MITFWT and the K243mutants. The results
were consistent with the ChIP-seq data as well as the in vitro
DNA binding in the presence of salmon spermDNA. SMTmovies
with a frame rate of 100 fps revealed that 45% of MITF WT was
immobile, a fraction higher than SOX2 (23%) or steroid receptor
(20%–40%), while slower acquisitions determined an average
residence time of 6 s, similar to that of other transcription factors
(Chen et al., 2014; Gebhardt et al., 2013; Loffreda et al., 2017;
Sugo et al., 2015; Teves et al., 2016; Morisaki et al., 2014; van12 Molecular Cell 79, 1–16, August 6, 2020Royen et al., 2011). Surprisingly, although the MITF non-DNA-
binding mutant exhibited a large decrease in the immobile frac-
tion, it also displayed an increase in the diffusion coefficients of
the diffusing populations. This indicates that 30% of MITF WT
diffusion is interdispersed with very transient (faster than the
acquisition rate) binding events to low-affinity sites that reflect
the proposed genomic reservoir, resulting in slower effective
diffusion coefficients. The other two MITF populations deter-
mined from the biexponential fitting of the distribution of resi-
dence times, accounting for 45%of themolecules, are represen-
tative of more stable (higher affinity) binding events. Importantly,
the high-affinity K243R mutant exhibited a significantly reduced
immobile fraction and an increase in both the fast- and slow-
diffusing fractions compared to the WT or K243Q mutant. This
reflects, in this orthogonal approach, the reduced DNA binding
by MITF K243R observed using ChIP-seq, and the data are
consistent with a greater proportion of the high-affinity K243R
mutant binding transiently to very low-affinity sequences
genome-wide, thereby reducing the pool of molecules able to
target sites bound better by the WT or K243Q mutant. Since
the bound fraction determines transcription burst frequency
(Stavreva et al., 2019), our results are consistent with the
K243Q or acetylated WT MITF, but not the K243R mutant, sup-
porting melanocyte development and promoting tumor growth.
Notably, in development, as shown by the ChIP-seq and SMT
assays, the MITF WT protein behaves much more like the
K243Q mutant than the K243R mutant, suggesting that under
the conditions used, a significant proportion of functional MITF
is acetylated. However, it is important to note that additional
post-translational modifications, including acetylation on other
residues not identified here, by p300/CBP or possibly other
acetyl transferases, or non-acetylationmodifications such as su-
moylation, phosphorylation, or methylation might also affect
MITF target specificity.
The increased binding observed after induction of MITF
expression using doxycycline is consistent with the rheostat
model for MITF function (Carreira et al., 2006) that suggests
that increasing MITF activity changes its corresponding gene
expression program. However, MITF ‘‘activity’’ is defined as a
combination of the amount of protein in a cell and post-transla-
tional modifications that affect function. Since we found no evi-
dence that mutation of K243 affects MITF protein levels, K243
acetylation status must control the effective concentration of
MITF by regulating its availability within cells. The K243-Ac/
K243Q is unable to bind the genome-wide excess of very low-af-
finity sites and consequently has a higher effective concentra-
tion; by contrast, unmodified K243 or the K243R mutant has a
lower effective concentration and less availability to bind key
regulatory elements, as it instead binds an excess of low-affinity
sites genome-wide. Since we show that CATGTG M-box motifs
associated with differentiation genes exhibit lower affinity
for MITF than CACGTG elements, we anticipate that transcrip-
tionally productive recognition of lower affinity sites may
require higher effective levels of MITF that may be achieved by
a combination of K243 acetylation as well as increased protein
levels, for example in response to MC1R signaling following
UV irradiation (Cui et al., 2007; Price et al., 1998; Malcov-Brog
et al., 2018).
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potentially other lysine acetyl-transferases, such as p300/CBP-
associated factor (PCAF) (Rodolosse et al., 2009) or GCN5
(Wang et al., 2020), may regulate their DNA-binding affinity. In
this respect, regulation of transcription factor acetylation may
be generally important. Significantly, lysine 243 in MITF is highly
conserved in most bHLH and bHLH-LZ transcription factors and
makes a similar phosphate backbone contact in available crystal
structures. Importantly, acetylation of the bHLH factor NEUROD
at K138 (the K243-equivalent residue) enhances its capacity to
regulate transcription (Qiu et al., 2004), and a K138Qmutation in-
creases the bound fractionmeasured by SMT.We therefore view
it as likely that acetylation-regulated genomic redistribution
achieved by moderately reducing a transcription factor’s affinity
for DNA may be a widespread mechanism for determining tran-
scription factor availability. Moreover, since p300 activity can be
regulated by MAPK signaling (Chen et al., 2007), the greatly
enhanced tumor-forming capacity observed with the MITF
K243Q mutant compared to K243R further suggests that tran-
scription factor acetylation driven by activated oncogenes like
BRAF will fuel proliferation in cancer in part by releasing tran-
scription factors from their genomic reservoir.
In summary, by regulating a transcription factor’s affinity for
DNA, the balance between the pool of molecules binding the
genomic reservoir and those recognizing productive binding
sites may be controlled. Our results suggest that competition
by an excess of low-affinity sites means paradoxically that
moderately reducing DNA-binding affinity may be crucial for
raising transcription factor availability above the threshold
required for productive gene regulation underpinning develop-
ment and tumorigenesis.STAR+METHODS
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Antibodies
HA Roche Cat# 11666606001; RRID: AB_514506
HA Sigma-Aldrich Cat# H3663; RRID: AB_262051
HA Cell Signaling Technology Cat# 2367; RRID: AB_2314619
FLAG Sigma-Aldrich Cat# F1804; RRID: AB_262044
Acetylated-Lysine Cell Signaling Technology Cat# 9441; RRID: AB_331805
MITF Millipore Cat# MAB3747; RRID: AB_570596
ERK 2 Santa Cruz Biotechnology Cat# sc-153; RRID: AB_2141293
ERK 2 Santa Cruz Biotechnology Cat# sc-1647; RRID: AB_627547
Thr202/Tyr204, ppERK Cell Signaling Technology Cat# 4377; RRID: AB_331775
Catenin, beta BD Biosciences Cat# 610154; RRID: AB_397555
USF2 Santa Cruz Biotechnology Cat# sc-862; RRID: AB_632580
Lamin B Santa Cruz Biotechnology Cat# sc-6216; RRID: AB_648156
GAPDH Santa Cruz Biotechnology Cat# sc-32233; RRID: AB_627679
Actin Santa Cruz Biotechnology Cat# sc-47778;RRID:AB_2714189
Histone H3 Abcam Cat# ab1791; RRID: AB_302613
H3K27Ac Cell Signaling Technology Cat# 8173BF; RRID: AB_2616015
MITF-K243 specific antibody This paper N/A
Bacterial and Virus Strains
Subcloning Efficiency DH5a bacteria Invitrogen Cat#18265-017
BL21(DE3) Agilent Technologies Cat#200131
Biological Samples N/A N/A
Chemicals, Peptides, and Recombinant Proteins
Doxycycline Sigma Cat# D9891
FuGENE 6 Promega Cat# E2692
Geneticin GIBCO Cat# 10131027
Puromycin GIBCO Cat# A1113802
MITF-recombinant proteins In house This paper
M344 Stratech Scientific Cat# S2779-SEL
cOmplete ULTRA Protease Inhibitor Cocktail Sigma Cat# 5892988001
Urea Sigma Cat# 51457-100ML
Guanidine hydrochloride Sigma Cat# G4505-100G
Imidazole Sigma Cat# 792527-100G
Ni-NTA His$Bind Superflow Resin Merck Cat# 70691
cOmplete ULTRA Tablets, Mini, EDTA-free Sigma Cat# 06538304001
Critical Commercial Assays
QIAquick PCR Purification Kit QIAGEN Cat# 28106
QuikChange Lightning Site-Directed Mutagenesis Kit Agilent Technologies Cat# 210519
PureLink Genomic DNA Mini Kit Invitrogen Cat# K182002
QIAprep Spin Miniprep Kit QIAGEN Cat# 27106
Qubit dsDNA HS Assay Kit Invitrogen Cat# Q32851
Agilent High Sensitivity DNA Kit Agilent Technologies Cat# 5067-4626
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Deposited Data
ChIP-seq 501mel Human melanoma cell line
ectopically expressing inducible HA-Mitf
GSE137522 This paper
ChIP-seq data of 501mel cells constitutively
expressing HA-Mitf
GSE77437 This paper
Experimental Models: Cell Lines
501mel Human melanoma cell line (female) Obtained from Ruth
Halaban, Yale
(Zakut et al., 1993) RRID:CVCL_4633
A375M Human melanoma cell line (male) ATCC (Fogh et al., 1977; Giard et al., 1973)
RRID:CVCL_B222
Phoenix-Ampho Human fetal cell line (female) ATCC RRID:CVCL_H716
501mel Human melanoma cell line ectopically
expressing inducible 3xHA-Mitf-WT
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible 3xHA-Mitf-K243Q
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible 3xHA-Mitf-K243R
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible NLS-HTN-Mitf-WT
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible NLS-HTN-Mitf-K243Q
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible NLS-HTN-Mitf-K243R
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible NLS-HTN-Mitf-basic
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic 3xHA-Mitf-WT
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic 3xHA-Mitf-K243Q
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic 3xHA-Mitf-K243R
In house This paper
501mel Human melanoma cell line ectopically
expressing inducible MITF-10HIS
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-3xHA-Mitf
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-3xHA-Mitf and inducible
EmGFP-MITF-WT
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-3xHA-Mitf and inducible
EmGFP-MITF-K243Q
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-3xHA-Mitf and inducible
EmGFP-MITF-K243R
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-NEUROD1-WT
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-NEUROD1-K139Q
In house This paper
501mel Human melanoma cell line constitutively
expressing ectopic HTN-NEUROD1-K139R
In house This paper
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Experimental Models: Organisms/Strains
Athymic nude mice, 7-9 weeks old Charles River Crl:NU(NCr)-Foxn1nu
Zebrafish nacre line Bred in house (Lister et al., 1999)
Oligonucleotides
SDM-primer K243Q 50-CAGACATGC
GGTGGAACCAGGGAACCATTCTCAAG
Eurofins This paper
SDM-primer K243R 50-ATCCAGACATGCG
GTGGAACAGGGGAACCATTC
Eurofins This paper
SDM -primer K21R50- CTTGCTGTATGTGGT
ACCTGGTGGGGTTTTCCAGG-30
IDT This paper
SDM -primer K33R50- TAGAAAGGTAC
TGCCTTACCTGGTGCCTCTGAGC-30
IDT This paper
SDM -primer K43R50- CTTGGCTGGCATG
TCTATTTGCTAAAGTGGTAGAAAGGTACT-30
IDT This paper
SDM -primer K248R50- CCACAGAGGCCCT
GAGAATGGTTCCCTTGTTCC-30
IDT This paper
NLS insertion-primer 50-CGCCTAGCGGCCG
CATGGCTCCGAAGAAGAAGCGGAAGGTAG
CTGATACCACCATG
IDT This paper
basic-primer 50-GAGCATTGGCTAAAGA
GAGGTTTAACATAAACGACCGCAT
IDT This paper
SDM-primer-NEUROD1-K138Q50- GACGCA
GAAGCTGTCCCAGATCGAGACTCTGCGCT
Eurofins This paper
SDM-primer-NEUROD1-K138R50- CGCAG
AAGCTGTCCAGAATCGAGACTCTGCG
Eurofins This paper
Sub-cloning of pHTN-Mitf into pPB-hCMV*1-cHA-pA
50-AAAGCCACCGCGGCCGCATGGCAGAAATCGG
TATTTCTAGAGCGGCCGCCTACACACCATGCTCC
GTTTCTTCTGCGCTCAT
IDT This paper
Insertion of EmGFP into pPB50- AGACTCA CAATTG
ATGGTGAGCAAGGGCGAGGAGC-305’ AGACTCA
GAATTC TGGGCTCGAGCCCTTGTACAGCTC-30
IDT This paper
Insertion of HIS-tag into pPB50- ATCGACTACAAGG
ATGACGATGACAAGCATCATCACCATCACCATCA
CCATCACCACTAGTGA-305’- GGGTAGGCCATGG
CACTAGTTCATCACTAGTGGTGATGGTGATGGTG
ATGGTGATGATG-30
IDT This paper
Genotyping primer 50-CACAGAGTCTGAAGCAA
GAGC50-CCGGTGGATGGGATAAGGGAAAGTC
IDT This paper
Fluorescence anisotropy probes (backbone)
50- GAGATCACGTGATGAC-30-Fluorescein
METABION This paper
EMSA probe 50-CTAGACTTGTGGAGA
TCACGTGATGACTTCCTGATTCCTCompetitor
probes have same backbone sequence
Eurofins This paper
BLOC1S1_ChIP-qPCRF 50-GATCTTCA
CCCAAGGTCTCAAR 50-AAGCTGGAACGCTCACC
IDT This paper
CDK4_ChIP-qPCRF 50-TGCTTCGACTGGGAGGAR
50-CAAGCGGTCACGTGTGATA
IDT This paper
GAPDH_ChIP-qPCR non MITF target –ve controlF
50-GAAGGGCTTCGTATGACTGGR 50-CTTAAG
GCATGGCTGCAACT
IDT This paper
GRIN2A_ChIP-qPCRF 50-CTGGCCCAATTC
TTCATCTCTR 50-GTCACGTGATCAAACTCAAAGTC
IDT This paper
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GTF2H1_ChIP-qPCRF 50-CTACTAACGGCA
CTTCCTCATCR 50-AGGCCGTAGAGAGCGTAAT
IDT This paper
KAT5_ChIP-qPCRF 50-GAGACGCCCGAGGACTTR
50-CGAAGCTGGTCACGTGTATG
IDT This paper
MTHFR_ChIP-qPCRF 50-CCTGGTCTCA
GTCCCAGAR 50-CTTCCTCCTTTACTGCCACTC
IDT This paper
SIRT1_ChIP-qPCRF 50-CTCGCCACAAA
GAGGAAGGR 50-CCACAACACTACGGGTCAC
IDT This paper
Recombinant DNA
Piggybac expression system (Magnu´sdo´ttir et al., 2013) (Magnu´sdo´ttir et al., 2013)
pPB-3xHA-Mitf-WT In house This paper
pPB-3xHA-Mitf-K243Q In house This paper
pPB-3xHA-Mitf-K243R In house This paper
pPB-MITF-10xHIS In house This paper
pCMV5-3xHA-Mitf-WT In house This paper
pCMV5-3xHA-Mitf-K243Q In house This paper
pCMV5-3xHA-Mitf-K243R In house This paper
pPB-NLS-HTN-Mitf-WT In house This paper
pPB-NLS-HTN-Mitf-K243Q In house This paper
pPB-NLS-HTN-Mitf-K243R In house This paper
pPB-NLS-HTN-Mitf-Dbasic In house This paper
pPB-NLS-HTN-Mitf-K21/33/43/248R In house This paper
pPB-3xHA-Mitf-K21/33/43/248R In house This paper
pHTN-3xHA-Mitf In house This paper
pPB-EmGFP-3xHA-MITF-WT In house This paper
pPB-EmGFP-3xHA-MITF-K243Q In house This paper
pPB-EmGFP-3xHA-MITF-K243R In house This paper
pEZ-HTN-NEUROD1 GeneCopoeia #EX-M0522-M49
pEZ-HTN-NEUROD1-K138Q In house This paper
pEZ-HTN-NEUROD1-K138R In house This paper
Software and Algorithms
STAR v 2.5.1b, Genome GRCh38 v23 (Dobin et al., 2013) N/A
Homer v4.9.1, Genome hg38 v5.10 (Heinz et al., 2010) N/A
ggplot2-v3.0.0 – under R-v3.5.1 https://cran.r-project.org/web/
packages/ggplot2/index.html
TreeView (Saldanha, 2004) N/A
Bowtie 1.1.2 (Langmead and Salzberg, 2012) N/A
PicardTools version 1.96, http://picard.sourceforge.net
seqMINER (Ye et al., 2011) N/A
deepTools (Ramı´rez et al., 2014) N/A
MACS2 v2.1.0 (Zhang et al., 2008) N/A
CisGenome (Ji et al., 2008) N/A
MEME (Machanick and Bailey, 2011) N/A
BedTools (Quinlan and Hall, 2010) N/A
BWAv0.7.8 N/A https://academic.oup.com/bioinformatics/
article/25/14/1754/225615
Bioconductor N/A https://www.bioconductor.org
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Colin R
Goding (colin.goding@ludwig.ox.ac.uk).
Materials Availability Statement
Plasmids and cell lines generated in this study are available upon request. The K243Ac-specific antibody is of limited-availability,
although we can provide information on supplier which may be used to procure additional material.
Data and Code Availability
The accession number for the ChIP-Seq datasets using constitutive or inducible HA-MITF reported in this paper are Gene Expression
Omnibus: GSE77437, GSE137522. All bioinformatics analyses were carried out using publically available packages as described in
METHOD DETAILS section. Original data have been depositied to Mendeley Data: https://doi.org/10.17632/2ccckzsk26.1.
Exemplary SMT movies are provided in Videos S1, S2, S3, and S4. Additional movie files are available on request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
In vivo animal studies
Zebrafish
Ethical statement. All zebrafish experiments are performed in accordance with the Animals (Scientific Procedures) Act 1986,
and approved by the University of Edinburgh Animal Welfare and Ethical Review Body.
Experimental procedures
Plasmid DNA (62.5 ng/ml) comprising the zebrafishmitfa promoter driving the fishMITF cDNAwasmixedwith Tol2mRNA (70 ng/ml). 2
nL of the mixture was injected into 1-cell stagemitf null nacre embryos. Injected embryos were grown at 28C for 5 days. On day 5,
embryos were briefly exposed to white light to contract melanocytes and were then imaged before being fixed in 4% PFA. The
total number of surface melanocytes in the head, trunk and yolksac was counted.
Experimental animals
Zebrafish AB/TPL lines were bred, raised and maintained as described (Westerfield, 2000).
Mouse
Ethical statement. Experiments were approved by the animal use ethical committee of Oxford University and fully complied with
UK Home Office guidelines.
Experimental procedures
1 3 106 cells in 100 ml PBS were subcutaneously injected into the flanks of 7-9 week old female athymic nude mice at day 1.
Tumor size was measured every three days with Vernier callipers. Tumor volumes were calculated using the following formula:
(L * W * W)/2, in which L represents the large diameter of the tumor, and W represents the small diameter. Animals were
sacrificed and the tumors isolated when a tumor reached approximately 1 cm diameter, or before.
Experimental animals
Healthy female athymic nude mice (Crl:NU(NCr)-Foxn1nu) aged 7-9 weeks were purchased from Charles River.
Experimental Models
Cell Lines
Human cell line information.
501mel Human melanoma cell line (female, RRID:CVCL_4633)
A375M Human melanoma cell line (male, RRID:CVCL_B222)
Phoenix-Ampho Human fetal cell line (female, RRID:CVCL_H716)
All melanoma cell lines were authenticated by STR analysis using Eurofins Genomic service. All parental and derivative cell
lines were verified mycoplasma free using Ludwig Cancer Research monthly mycoplasma check service.
Culture/Growth condition
Melanoma cell lines and their stable transfectants were grown in RPMI-1640 (GIBCO BRL, Invitrogen), supplemented with 10% fetal
bovine serum (FBS, Biosera). Phoenix-ampho cells were grown in DMEM (Lonza), supplemented with 10% FBS. Cells were main-
tained in humidified incubator at 37C with 10% CO2.
Bacterial Strains
Escherichia coli BL21(DE3) cells, Genotype: B F– dcm ompT hsdS(rB
– mB
–) gal l(DE3) (Agilent Technologies #200131).
Escherichia coliDH5a bacteria Genotype: F-F80lacZDM15D(lacZYA-argF) U169 recA1 endA1 hsdR17(rk
-, mk
+) phoA supE44 thi-1
gyrA96 relA1 l- (Invitrogen #18265017)Molecular Cell 79, 1–16.e1–e10, August 6, 2020 e5
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Plasmids
pCS2-6x Myc-MITF has been described previously (Schepsky et al., 2006). pCMV14-3 3 FLAG-MITF was made by insertion of the
MITF mouse cDNA from the ATG start codon, but lacking a stop codon into the vector polylinker and expresses MITF with a C-ter-
minal triple flag epitope. pcDNA3-3 3 HA-MITF was constructed by inserting the MITF cDNA from the ATG start codon to the stop
codon, and pETM-11-MITFDN180DC296 has been described (Pogenberg et al., 2012). The doxycycline-inducible 3xHA-Mitf
plasmid was made through PCR-mediated sub-cloning of pCDNA5-3xHA-Mitf into pPB-hCMV*1-cHA-pA (Magnu´sdo´ttir et al.,
2013) using EcoRI-HF (NEB; Cat#R3101L). pHTN-Mitf was sub-cloned from pCDNA5-3xHA-Mitf using EcoRI-HF. The doxycy-
cline-inducible Halo-tag-Mitf plasmids were generated through sub-cloning of pHTN-Mitf into pPB-hCMV*1-cHA-pA using NotI-
HF (NEB; Cat#R3189S). The NLS derived from SV40 and 10xHIS-tag were introduced into pPB-HTN-Mitf and pPB-MITF,
respectively through PCRmediated insertion and point mutations were introduced using QuikChange Lightning Site-Directed Muta-
genesis Kit (Agilent; Cat# 210519). The basic domain of Mitf was removed through PCR-mediated deletion to generate the pNLS-
HTN-Mitf-Dbasic construct. pPB-EmGFP-3xHA-MITF was generated through PCR mediated subcloning of EmGFP from
pcDNA6.2-N-EmGFP-GW into pPB. pEF-Myc-BRAFV600E was a gift from Richard Marais, pcDNA3-3 3 HA-p300 was a gift from
Bernhard Luescher. All plasmids were sequenced prior to use.
Stable cell line generation
501mel cells stably expressing HA-epitope tagged WT MITF have been described (Strub et al., 2011). 501mel melanoma cell
lines ectopically expressing inducible Mitf were generated by co-transfecting pPB-3xHA-Mitf with pPB-rttA and pPB-transposase
in an 8:1:1 ratio using Fugene 6 (Promega; Cat# E2692) at a 3:1 FuGENE 6:DNA ratio. Cells were initially selected for pPB-rttA using
1mg/ml Geneticin (GIBCO; Cat# 10131027) then for pPB-3xHA-Mitf with 5 mg/ml Puromycin (GIBCO; Cat# A1113802). The resulting
cell lines were genotype for integration of the corrected mutant through sequencing of amplicon PCR-amplified from genomic
DNA extracted using PureLink Genomic DNA Mini Kit (Invitrogen; Cat# K182002). Clonal populations were selected, dissociated
and expanded before being analyzed for appropriate HA-MITF expression. 501mel cells stably expressing Halo-tag Mitf and
NEUROD1 were generated through transient transfection of plasmids using Fugene 6 at a 3:1 FuGENE 6:DNA ratio for 3 rounds
as the cells were successively passage from 6 cm to 10 cm dish and to T75 flask before selection in 1mg/ml Geneticin till stably
ectopically expressing cell lines were obtained.
Western blotting
Hot LDS Sample Buffer (Invitrogen; Cat# NP0008) supplemented with b-mecaptoethanol (Sigma; Cat# M6250) was used to lyse
cells before being subjected to SDS-PAGE using either a 19:1 ratio of acrylamide:bis-acrylamide, or a 200:1 ratio, as in Figure 2A,
to allow better resolution of phosphorylated proteins. Note that the 200:1 ratio leads to proteins exhibiting an apparent increase in
molecular weight if they are modified. Proteins transferred to Immobilon-FL polyvinylidene difluoride membranes (Millipore; Cat#
IPFL00010) that were blocked with 5% non-fat milk, in TBS containing 0.1% Tween-20 (TBS-T) before probing with primary
antibodies in 5% BSA-TBS-T overnight at 4C. Proteins were detected using HRP-conjugated secondary antibodies (Bio-Rad,)
and detected using an enhanced chemiluminescence (GE Healthcare) using X-ray film (Fuji) or Alexa Fluor-conjugated secondary
antibodies and visualized using ChemiDoc MP (Biorad).
Immunofluorescence
Cultured cells were grown to 80% confluence and fixed in 4% PBS-paraformaldehyde for 10 minutes, and incubated in 0.2%
Triton X-100 for 10 minutes followed by 5% BSA in PBS-T for 30 minutes. Samples were stained with primary antibody overnight.
After 3 washes of PBS-T, secondary antibody staining was performed for 1 h and samples mounted in Vectashield mounting
medium containing DAPI (Vector Laboratories).
Immunoprecipitation
Cell pellets were washed in ice-cold PBS and suspended in lysis buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, supplemented with 1 3 protease inhibitor and 1 3 phosphatase inhibitor cocktails [both Roche], 10 mM sodium butyrate,
10 mM nicotinamide) for 10 min on ice and clarified by centrifugation at 13,000 rpm, 10 min. After retaining an input fraction, samples
were incubatedovernight with rotationwith 1 mg antibody. 50ml of a 50%proteinG-agarose bead slurry (Roche), previously equilibrated
in lysis buffer, was added and the samples rotated for a further 2 hours. After extensive washing in lysis buffer, beads were boiled in hot
23 SDS-PAGE loading buffer. For FLAG IPs, 20 mL of a 50% slurry of anti-FLAG (M2)-conjugated protein G-agarose beads, previously
equilibrated in lysis buffer, was directly added to the clarified lysate overnight before washing and boiling.
GFP- and HIS-tag pull down
GFP-tagged MITF were purified using GFP-trap (Chromotek Cat#gtma-100) from transiently transfected Phoenix-ampho with
indicated plasmids (total 6 mg DNA in 6 cm dish) using Fugene 6. The cells were lysed in 500 mL RIPA supplemented with 5 mM
M344 (Stratech Scientific Cat#S2779-SEL) and 4xPIC (Sigma Cat#5892988001) on ice 30 mins before passing through 25 guagee6 Molecular Cell 79, 1–16.e1–e10, August 6, 2020
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Supernatant was used for GFP pull-down overnight, wash 3 times and eluted in LDS.
HIS-tag MITF were purified using Ni-NTA His$Bind Superflow Resin (Merck Cat#70691) from 501mel cells stably expressing
ectopic MITF-10xHIS. Cells pelleted from 15 cm dish were lysed in 1mL lysis buffer (6M guanidinium HCl, 0.1 MNa2HPO4/NaH2PO4,
10mM Tris-HCl (pH8), 0.005M imidazole, 0.01M bME) and briefly sonicated before pre-clearing through centrifugation, 14,000 x g,
10 mins. Supernatant is transferred to 15ml LoBind tube with extra 4 mL lysis buffer. 100 mL of washed and pre-equilibrated Ni-NTA
resin in lysis buffer was added to the supernatant and rotated overnight, 4C before washing 1x in lysis buffer, 1x wash buffer (8 M
Urea, 0.1 M Na2HPO4/NaH2PO4, 10 mM Tris-HCl (pH8), 0.005 M imidazole, 0.01 M bME), 2x wash buffer + 0.1% Triton X-100
with 5 min on rotating wheel at room temperature between each wash and eluted in LDS.
Mass spectrometry and sample preparation
Cells were transfected with a mammalian Myc-epitope-tagged murine MITF expression vector together with expression vectors
for p300. 48 h post-transfection cells were harvested, and whole cell lysate used for immunoprecipitation using anti-Myc antibody.
Immunoprecipitates were resolved using SDS-PAGE and gel bands corresponding to MITF were excised, destained then reduced
and alkylated and digested with chymotrypsin overnight. Digests were analyzed using a LTQ XL Orbitrap (Thermo, Hemel Hemp-
stead), coupled to aDionex Ultimate 3000 nanoHPLC system (Camberley, Surrey). Datawere analyzed usingMascot (Matrixscience,
London). Precursor mass tolerance was set to 10 ppm, fragment mass tolerance was 0.5 Da, fixed modification was carbamidome-
thylation of cysteine and variable modification was oxidised methionine and acetylated lysine. Data were searched against an IPI
mouse database.
Recombinant protein purification
MITF DNA-binding domains (residues 180-296) that were either WT, K243Q or K243R were expressed in Escherichia coli BL21(DE3)
cells (Agilent Technologies). Cultures were grown in Luria-Bertani broth to an OD600 of 0.7-0.8. Recombinant protein overexpression
was induced by addition of isopropyl b-D-1-thiogalactopyranoside (IPTG; 0.5 mM final concentration) and the cultures were incu-
bated for a further 6 h. Cells were harvested by centrifugation, washed in PBS and frozen on dry ice. After thawing, cells were
suspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 10% v/v glycerol, pH 7.4 [NaOH], 20 mg/ml lysozyme
[Invitrogen], 1 3 protease inhibitor cocktail [Roche]). Cells were lysed by sonication and centrifuged. Clarified lysate was mixed by
rotation with a 50% Ni-NTA slurry (QIAGEN) previously equilibrated in lysis buffer and loaded in gravity flow columns (Bio-Rad).
After extensive washing in wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 10% v/v glycerol, pH 7.4 [NaOH]), bound
material was serially eluted in elution buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 10% v/v glycerol, pH 7.4 [NaOH]).
Fractions were analyzed by SDS-PAGE and Coomassie staining to determine purity, and pure fractions were pooled and glycerol
added to a final concentration of 30% v/v.
Circular dichroism (CD) spectropolarimetry measurements
Prior to eachmeasurement, samples were dialyzed against 10mMpotassium phosphate pH 7.5, 150mMNaF and diluted to 0.25mg
xml-1. Spectra were recorded at 10Con aChirascan CDSpectrometer (Applied Photophysics), between 185 and 260 nm in a 0.1 cm
cuvette. Machine settings were as follows: 1 nm bandwidth, 0.5 s response, and 1 nm data pitch. Spectra were background
subtracted and converted to mean residue ellipticity.
Fluorescence anisotropy assay
The following fluorescein-labeled oligonucleotides were synthesized at METABION (Planegg/Steinkirchen, Germany):
Consensus: 50- GAGATCACGTGATGAC-30-Fluorescein
E-box: 50- GAGACCACGTGTTGAC-30-Fluorescein
M-box: 50- GAGATCATGTGTTGA C 30-Fluorescein
HS: 50- GAGATCACGACTTGAC 30-Fluorescein
These oligonucleotides were annealed with complementary unlabeled oligonucleotides through incubation at 95C for 5 min,
followed by a passive cooling step to room temperature. Increasing concentrations of MITF proteins were incubated with the
respective dsDNA oligonucleotides at a final concentration of 1.33 nM at 25C for 5 minutes in 10 mM Tris/HCl pH 7.5, 300 mM
NaCl, 0.01% TRITON-X100, and 0.1 mg/mL BSA. Fluorescence anisotropy was then measured using an Infinite M1000 plate
reader (TECAN) using the excitation diode at 470 nm and detecting the emitted light at 530 nm.
Electrophoretic mobility shift assays
EMSAs were performed by incubating equal amounts of recombinant proteins diluted in bandshift buffer (25 mM HEPES [pH 7.4],
150 mMKCl, 10% v/v glycerol, 200 mg/ml BSA, 5 mMDTT) for 20 min in the presence or absence of cold competitor oligonucleotides
or sonicated salmon sperm DNA (Agilent), prior to addition of 32P-labeled oligonucleotide (labeled at both ends with a32-P-dCTP,
Perkin Elmer) and loading on 6% native acrylamide gels. Gels were dried and visualized by autoradiography. The oligonucleotideMolecular Cell 79, 1–16.e1–e10, August 6, 2020 e7
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Subcellular-fractionation
Cell pellets were re-suspended in 5 pellet volumes of ice-cold nuclear-isolation buffer (10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM
MgCl2, 0.5 mMDTT, 10mM sodium butyrate, 43 PIC) and rotated at 4
C for 10min before NP40 was added to a final concentration
of 0.5% and incubated for a further 5 min. Plasma membrane breakdown was confirmed under the light microscope before
centrifugation at 5,000 3 g for 10 min. The resulting supernatant constituted the cytosolic fraction while the pellet was further resus-
pended in 3x pellet volumes of nuclear extraction buffer (20 mM HEPES (pH 7.9), 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25%
glycerol, 0.5 mM DTT, 10 mM sodium butyrate, 43 PIC), 4C, 10 min then centrifuge at 13,000 3 g for 10 min. The supernatant cor-
responded to the nucleoplasmic fraction. The insoluble pelletwas further resuspended in 3 x pellet volumeof nuclear extraction buffer +
10 ml Lysonase (Millipore; Cat# 71230) and incubated 20 min room-temperature followed by centrifuge at 13,000 3 g,10 min. All four
fractions were reconstituted to the same final volume in LDS buffer such that each ml corresponded to the same fraction of cells.
Alternatively, cells were pelleted from a 10 cm dish is resuspended in 500 ml resuspension buffer (20 mMPipes pH 6.8, 1mMEGTA
pH 6.8, 1 mM MgCl2, 1 x PIC) and incubated on ice 5 min before Triton X-100 was added to a final concentration of 0.5%. Plasma
membrane breakdown was confirmed under the light microscope before centrifugation at 900 3 g for 5 min, 4C. The supernatant
corresponds to the cytosolic fraction (Fraction 1). The nuclear pellet was resuspended in 500 ml nuclear extraction lysis buffer
(100 mM KCl, 300 mM Sucrose, 10 mM Pipes pH 6.8, 3 mM MgCl2, 1 mM EGTA, 1 x PIC and 100 mg/ml DNase) and incubated at
30C for 45 min with gentle agitation before centrifugation at 1500 3 g for 5 min at 4C. The supernatant corresponds to Fraction
2. The pellet was further resuspended in 375 ml nuclear extraction lysis buffer + ammonium sulfate to a final concentration of
0.25 M and incubated for 10 min at RT with gentle agitation before centrifugation at 1500 3 g for 5 min at RT. The supernatant
corresponds to Fraction 3. The pellet was then resuspended in 300 ml ice-cold nuclear extraction lysis buffer plus NaCl to a final
concentration of 2Mand incubated on ice for 10min before centrifugation at 4,0003 g for 5min at 4C. The supernatant corresponds
to Fraction 4 while the pellet corresponds to insoluble nuclear matrix protein, Fraction 5.
ChIP-seq
Cells from three 80% confluent 15 cm dishes were trypsinised, collected into a 50 ml falcon tube ðCorning; Cat# 430828Þ,
centrifuged ð800 3 g; 4 minÞ and media aspirated. Cross-linking was done by adding 45 ml ice-cold PBS contai-
ning 0:4% paraformaldehyde. Cells were rotated 10 min at RT before quenching with glycine to a final concentration
of 0:2 M for 10 min. Samples were then washed and centrifuged ð1500 3 g; 10 minÞ. A total of thirty 15 cm dishes were used for
each replicate of ChIP-seq. Lysis was done in 1 ml ChIP lysis buffer (50 mM Tris-HCl (pH 8:0), 10 mM EDTA, 10 mM sodium butyr-
ate, 1% SDS, 43PIC (Roche; Cat#05056489001)) by passing the cell suspension through a 25 guage needle until there were no
visible clumps before sonicated for approximately 12 min in a Covaris S220 (Peak incident = 145W, Duty Factor = 8%, Cycle/Burst =
200) until 200 400 bp fragments were obtained (assessed by Bioanalyzer using Agilent High Sensitivity DNA Kit (Agilent; Cat#
5067-4626). The sonicated chromatin was cleared by centrifugation at 13;000 3 g for 10 min and the supernatant diluted 8-fold
in ChIP dilution buffer (16:7 mM Tris (pH 8:0), 167 mM NaCl, 1:2 mM EDTA, 1% Triton X100, 0:01% SDS) before 120 mg of
anti-HA antibody (Roche; Cat# 11666606001) was added and chromatin rotated in a 50 ml falcon tube overnight. In parallel 550 ml
Dynabeads G were washed, resuspended in ChIP dilution buffer, and blocked in 0:5 mg=ml BSA overnight. Immunoprecipitation
was carried out using blocked-Dynabeads, rotated for 1 hr, 4C. The beads were washed three times each in low salt wash buffer
(20 mM Tris-HCl (pH 8:0), 150 mM NaCl, 2 mM EDTA, 1% Triton X100, 0:1% SDS), high salt wash buffer (20 mM Tris-HCl
(pH 8:0), 500 mM NaCl, 2 mM EDTA, 1% Triton X100, 0:1% SDS) and LiCl wash buffer (10 mM Tris-HCl (pH 8:0), 250 mM LiCl,
1 mM EDTA, 1%sodium deoxycholate, 1%NP40Þ with beads transferred to a new DNA LoBind tube (Eppendorf; Cat# Z666548)
with each wash. The beads were eluted in 0:2 ml elution buffer (100 mM NaHCO3, 1% SDS). Reverse cross-linking of ChIPed-DNA
was done at 55C overnight with addition of 0:3 M NaCl (final concentration), 20 mg RNase A (Invitrogen; Cat# 12091021) and
20 mg Proteinase K (Roche; Cat# 3115828001). Recovery of ChIPed-DNA was done using QIAquick PCR Purification Kit (QIAGEN;
Cat# 28106). The concentration of ChIPped-DNA was assessed using Qubit dsDNA HS Assay Kit (Invitrogen; Cat# Q32851).
Alternately, cells were lysed in ChIP lysis buffer and chromatin sheared to around 300 bp for 16minutes in a Covaris S220 at 140W
Peak Incident Power, 5% Duty Cycle and 200 Cycles per Burst. 70 mg chromatin was diluted 9 times in ChIP dilution buffer and pre-
cleared for 2 hours at 4Cwith 50 mL of 50%protein-G Sepharose slurry (Roche), previously blocked with 0.5mg/ml BSA and 0.5mg/
ml sonicated salmon sperm DNA. The supernatant was incubated overnight with 5 mg of anti-HA antibody (clone 12CA5, Roche)
before 50 mL pre-blocked protein-G Sepharose slurry was added for 1 hour. Beads were washed two times each in low salt buffer,
high salt buffer, LiCl buffer and TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Chromatin was eluted in elution buffer, cross-links
were reversed overnight at 65C with 0.3 M NaCl and 10 mg RNase A followed by addition of 4 mM Tris-HCl (pH 8.0), 10 mM EDTA
(pH 8.0) and 20 mg Proteinase K (Fermentas) for 1 hour at 42C, and DNA purified with phenol-chloroform before ethanol precipitation
with 1 mg glycogen [Roche]. Samples which showed enrichment at expected targets on qPCR (as described in Louphrasitthiphol
et al., 2019) were subjected to sequencing using a HiSeq 4000 ðIlluminaÞ at the Wellcome Trust genomic service.e8 Molecular Cell 79, 1–16.e1–e10, August 6, 2020
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All fastq files were quality checked with FastQC. Reads from steady state experiments were aligned to human genome build hg19
(GRCh37v75) using Bowtie 1.1.2 (Langmead and Salzberg, 2012), allowing for 1 mismatch. Duplicate reads were discarded using Pic-
ardTools version 1.96, http://picard.sourceforge.net. Library-count normalized read density was examined at specific loci using the
University of Santa Cruz (UCSC) Genome Browser. Read density clustering of normalized libraries was performed with seqMINER
(Ye et al., 2011) and heatmaps drawn with deepTools (Ramı´rez et al., 2014); the regions within each cluster were further sorted by
maximal WT MITF read density. Average read density profiles were generated with BedTools. Peaks were identified using MACS2
v2.1.0 (Zhang et al., 2008) and associated with a gene if they fell within 20 kb of the gene body of a RefSeq gene using CisGenome
(Ji et al., 2008).De novo consensus motifs were predicted with MEME (Machanick and Bailey, 2011) by interrogating the 60 bp around
the summits of peaks. The coordinates of all CATGTG and CACGTGmotifs were determined genome-wide and overlapped with peak
coordinates using BedTools (Quinlan andHall, 2010).Melanoma patient H3K27acChIP-Seq fromGEO series GSE6066 (Verfaillie et al.,
2015) and bigwig files analyzed as above.MelanocyteMITF ChIP-Seq fromGSE50681 (Webster et al., 2014) was processed as above.
All additional steps were performed in R (Sato et al., 1997).
To exclude bioinformatics pipeline-specific artifacts, inducible MITF ChIP-Seq samples were processed in two independent
ways with similar results obtained with both methods. First: alignment to human genome build hg38 (GRCh38v23) with STARv
2.5.1b (Dobin et al., 2013); downstream analysis including peak calling and annotation, gene ontology analysis, bedgraph generation
and de novo motif identification using the exact peak coordinates conducted with Homer (Heinz et al., 2010); histograms of read
density were visualized using TreeView (Saldanha, 2004). Second: reads were aligned to human genome build hg19 (GRCh37v75)
with BWAv0.7.8 and duplicate reads marked with PicardTools; peaks were called with MACS2 using a minimum FDR of 0.001
and annotated with Homer; input-corrected bigwig files were generated with deepTools motif analysis was carried out with Bed-
Tools; consensus motifs were identified with MEME using a 60 bp sequence centered on the peak summit.
Single molecule tracking
Cells stably expressing HaloTag-MITF (WT ormutant) under the control of a doxycycline inducible promoter were plated in 4-well Nunc
Labtek Chambers (Thermo-Fisher, Milan, Italy). 24 h after induction with 20 ng/ml of doxycycline, HaloTag-MITFwas labeled by adding
100 pM of the cell-permeable HaloTag ligand Janelia Fluor 549 (Janelia Farm, Ashburn, VA, USA) to each of the wells. The cells were
incubated with the dye for 30’ and then extensively washed with PBS (3 washes), followed by an incubation step (20’ at 37C in cell
culture medium) and one last wash with PBS, and one with cell culture medium. The acquisition of single molecule movies were per-
formed on a previously described custom-madeHiLomicroscope (Loffreda et al., 2017), equippedwith a temperature andCO2Control
(set to 37C and 5% respectively). For the estimation of diffusion coefficients and bound-fractions, we used a laser exposure of 2 ms
and an acquisition frame rate 100 fps and collected 1000 frames/movie. Fluorescencewas excitedwith a 561 nmsolid-state laser (IFlex
Mustang, QiOptiq) and with a laser power density of approximately 1.2 kW/cm2. Movies were tracked and analyzed using our previ-
ously described software developed inMATLAB (Loffreda et al., 2017;Mazza et al., 2013). Briefly, the resulting tracks are used to popu-
late the histogram of the distribution of displacements (with a bin size Dr = 20nm), that is then fit with a three-component diffusion
model, that gives the probability of observing a displacement in the interval ½rðDr =2Þ; r + ðDr =2Þ
pðrÞ = rDr
X3
i = 1
Fi
2DiDt
exp

 r
2
4DiDt

Where Dt is the interval between two acquisitions (10 ms) and Fi is the fraction of molecules with diffusion coefficient equal to Di. To
provide standard deviations on the fitting parameters a jackknife procedure was adopted as described in Elf et al. (2007) and Loffreda
et al. (2017). Briefly, we performed multiple fitting iterations, each of them after dropping 20% of the data for each of the dataset.
Errors are provided as standard deviations of the obtained distribution of parameters following 200 individual fitting iterations.
The diffusion coefficient of the slowest diffusing component D1 = 0:07ðmm2 =sÞ, compatible with the diffusion coefficients of chro-
matin bound proteins (Chen et al., 2014), and F1 therefore represent the fraction of molecules detected as immobilized to chromatin
(as further validated by analyzing the MITF-Dbasic mutant). The MITF-Dbasic mutant also result in the increase of the diffusion co-
efficients of the unbound population, D2 and D3. In previous work this kind of observation has been interpreted as the presence of
transient binding (at a time-scale faster than the acquisition rate) slowing down diffusion of the WT protein, named effective diffusion
(Elf et al., 2007; Sprague et al., 2004). In our case, the free populations of theWTMITF and K243mutants are all similarly slowed down
compared to MITF-Dbasic (Figure 6E), indicating that transient non-specific binding affects all these three forms of MITF. We can
calculate the number of detectable long-lived binding events (longer than Dt) occurring in a cell at any given time ðNsÞ, by knowing
the number of MITF molecules NMITF , as: Ns =NMITF$F1. Here for NMITF we have used MITF 250,000 dimers estimated by comparing
the level of MITF detected in a western blot from 501mel cells compared to that detected using the same anti-MITF antibody of a
dilution series of a known concentration of bacterially expressed and purified MITF. Similarly, in the case of effective diffusion the
number of transient binding events Nns can be estimated by comparing the diffusion coefficients of the free populations of WT
MITF and K243 mutants to the diffusion coefficients of the MITF-Dbasic mutant, as Elf et al. (2007) and Sprague et al. (2004):Molecular Cell 79, 1–16.e1–e10, August 6, 2020 e9
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Where, Dfree; MITF refers to the diffusion coefficients of the free population of the one of MITF proteins (WT or K243 mutants)
and Dfree;Dbasic refers to the diffusion coefficients of the free population of the MITF-Dbasic mutant. As two diffusion coefficients
(D2andD3) are estimated for the free populations of each of the protein we provideNns as a range, where the two limits of the interval
are calculated using ðD2;MITF =D2; DbasicÞ and ðD1; MITF =D1;DbasicÞ respectively. The residence time of this transient binding
events cannot be measured, as it is faster than the acquisition frame rate.
For the measurement of MITF residence times at more stable binding sites (those resulting in the immobile fraction described
above), we scaled down the laser power by a factor 20, and collected movies using long exposures (200 ms exposures,
frame rate 2 Hz), in order selectively image immobilized molecules due to motion blur of diffusing MITF (Chen et al., 2014). The
complement cumulative distribution of the duration of binding events 1 CDFðtÞ were fitted a two-component exponential decay
(Chen et al., 2014; Loffreda et al., 2017):
1CDFðtÞ= f1 exp

 t
t1

+ ð1 f1Þexp

 t
t2

To extract the characteristic intermediate-lived t1 and long-lived t2 binding times to sites and the fraction of binding events f1 and
1 f1 occurring at these sites. The average residence time is then calculated as:
<t > = f1t1 + ð1 f1Þt2
QUANTIFICATION AND STATISTICAL ANALYSIS
Figure 1B. Top 900 significant peaks defined top 900 ranked peaks from MACS2 v2.1.0 output against background control.
q-value cutoff = 0.05
Figure 1F. Boxplots show the interquartile range (IQR), with the median value marked by the line transecting the box. Values
falling outside the IQR but within the range of IQR ± 1.5 3 IQR are shown by the dashed line whisker. Where included, the notch
indicates the 95% confidence interval about the median, and further outliers represented by dots.
Figure 3C. Binding data were analyzed using the GraphPad Prism software. Binding profiles were fitted using a simple model
assuming a stoichiometry of one MITF dimer per double stranded DNA fragment. When KD values were higher than 500 nM,
the maximum specific binding value (Bmax) was estimated according to the one obtained from other variants and maintained
fixed for the fitting. KD values reported correspond to the means of three independent measurements and the ± error numbers
represent the standard deviations.
Figure 4A. p-values were calculated using a Two-Sample t-test, and the line in the box and whisker plots indicates the mean.
The exact number of embryos injected and melanocytes count are shown in Figure S3.
Figure 4E. p-values determined using Student’s t-test when comparing WT and K243Q mutant is % 0.003. Error-bar
indicated SEM.
Figure 5A. Center of the peaks were defined as the summit of each individual peak. The number of row = 103911, derived from
WT 20 ng reference.
Figure 5B.
All peaks were called using the following fixed parameters
# FDR rate threshold = 0.001000000
# Fold over input = 4.00
# Poisson p value over input = 1.00e-04
# Fold over local region = 4.00
# Poisson p-value over local region = 1.00e-04
and variable parameters (modeled according to each dataset as these are sequencing depth dependent)
# FDR effective poisson threshold
# FDR tag threshold
Figure 5E. Boxplots show IQR with median value marked by line of the same color as the box and mean value marked by
black line. Whiskers cover values between IQR and ± 1.5 3 IQR. Any values outside 1.5 3 IQR are plotted with circle.
Figures 6C–6F. Ncells = 20; 6; 15; 15; Ndisplacements = 17802; 2684; 16422; 12999 for MITF WT, Dbasic, K243Q, K243R respec-
tively. Error bars indicate SD.e10 Molecular Cell 79, 1–16.e1–e10, August 6, 2020
